HPV vaccination in Southeast Asia and West Pacific Region

Cross-country Learning and Best Practices from HPV vaccination Programs

2, 3 and 4 of October 2024 – Manila, Philippines

Interactive Session | Day 1 | Day 2 | Day 3 | Poster Session

Symposium Objectives:

  • Explore and discuss the regional context of HPV vaccination
  • Cross-country learning on key priorities for HPV vaccination introduction, and sustainability in the region
  • Discussing program implementation and evidence-based policies in and across countries
  • Cross-country learning on HPV vaccine scheduling, delivery strategies, target age cohort, dropout rates for second dose, single-dose evidence and implementation, integration and optimization opportunities, and other key topics
  • Review challenges, successes, and strategies for improving HPV vaccination coverage
  • Develop a country specific action plan for sustainable HPV vaccination program: discuss key steps, best practices, and priorities
  • Discuss and draft research agenda to advance HPV vaccination programs in the region

Countries Interactive Session – HPV Situational Snapshot

Country Snapshots

Participating Countries

  • Brunei Darussalam
  • Kingdom of Cambodia
  • The People’s Republic of China
  • India
  • Indonesia
  • Lao PDR
  • Malaysia
  • Mongolia
  • The Republic of the Union of Myanmar
  • Nepal
  • Pakistan
  • Philippines
  • Singapore
  • Thailand
  • Timor-Leste
  • Vietnam

DAY 1: 2 October 2024

Day 1 Welcome

videos | pdfs
  • Opening Speech – Welcome
    Dr Glenn Mathew G. Baggao (Undersecretary of Health for the Public Health Services Cluster, Department of Health, Philippines)
  • Welcome note – Jhpiego Country Director Philippines
    Dr. Ingrid Magnata (Jhpiego, Philippines)
  • CHIC Symposium Objectives and Housekeeping rules
    Prof. Alex Vorsters
  • Participants Introduction

Session 1: Cervical cancer elimination and HPV vaccination Landscape

videos | pdfs

Chairs: Dr. Janis Asuncion Bunoan-Macazo (DOH Philippines) & Dr. Supakorn Pitakkarnkul (National Cancer Institute, Thailand)

  • Regional overview: Cervical cancer epidemiology and HPV vaccination progress; Western Pacific Regional Overview
    Dr Gloria Cho Heeyoun
  • Regional overview: Cervical cancer epidemiology and HPV vaccination progress; SEARO regional overview
    Dr Emmanuel Njambe Tondo Opute
  • Q&A

Session 2: Countries Interactive Session – HPV Situational Snapshot

Facilitators: CHIC Secretariat (Dr. Ricardo Burdier, University of Antwerp and Ms. Elaine Charurat, Jhpiego)

  • Orientation for interactive session
  • Interactive Session: Country HPV vaccination snapshot

Session 3: Regional HPV Vaccination Investments

videos | pdfs

Chairs: Dr. Chris Morgan (Jhpiego,US) & Prof. Youlin Qiao (National Cancer Center, China)

  • Gavi Investments
    Ms. Emily Kobayashi
  • Gates Foundation Investments in HPV Delivery
    Dr. Tanjila Taskin
  • DFAT Australia Funding Options
  • Q&A

Session 4: Policy, Schedule and Vaccine Product Choice

videos | pdfs

Chairs: Prof. Soe Lwin Nyein (NITAG, Myanmar) & Dr. Didik Setiawan (ITAGI, Indonesia)

  • Single-dose scientific evidence data and implementation progress
    Prof. Deborah Watson Jones (LSHTM, UK)
  • Considerations for HPV Vaccine product choice
    Dr. Hiroki Akaba (WHO, Philippines)
  • Decision-making to switch to single dose
    Dr. Soe Lwin Nyein (NITAG, Myanmar)
  • Q&A

Session 5: HPV Vaccination Implementation Strategies

Session 5a: Multi-sectoral Coordination and Partnerships

videos | pdfs

Chairs: Dr.Tanjila Taskin (Gates Foundation, USA) & Dr. Putri Herliana (CHAI, Indonesia)

  • Indonesia: Multi-sectoral engagement and coordination approaches for HPV vaccine national scale-up
    Ms. Hashta Meyta (EPI, Indonesia)
  • Malaysia: Partnership with CSOs for HPV vaccine coverage recovery
    Dr. Jason Chin (National Cancer Society)
  • Q&A
  • Panel Discussion: Strengthening multi-sectoral coordination and partnerships
    • Moderator: Session 5a appointed chairpersons
    • Cambodia: Experience of NGOs supporting MOH –
      • Dr. Seungwoo Kang (CHAI, Cambodia)
    • Myanmar: Coordination experience from MoE perspective
      • Ms. Twae Tar Loon (Department of Basic Education)

Session 5b: Social Mobilization, Demand Generation and Communication

videos | pdfs

Chairs: Dr. Anthony Calibo (Jhpiego, Philippines) & Dr. Edina Amponsah-Dacosta (University of Cape Town, South Africa)

  • UNICEF work on social mobilization, demand generation and communication
    Dr. Michelle Dynes – UNICEF
  • Thailand experience with communication and scale up of HPV vaccination program
    Dr. Suchada Jiamsiri (Department of Disease Control, Thailand)
  • Panel Discussion on Lessons from Country experiences on Communication strategies and Coverage Enhancement.
    • Moderator: Session 5b appointed chairpersons
      • Lao PDR – Dr Kongxay Phounphenghack Xay (EPI Manager)
      • Timor-Leste – Mr. Manuel Mausiry (EPI Manager)
      • UNICEF – Dr. Michelle Dynes (Online)

Day 2: 3 October 2024

Day 2 – Opening

videos | pdfs
  • Feedback of Day 1 – Participants
    Prof. Alex Vorsters

Session 5c: Service Delivery – Lessons Learned and Best Practices

videos | pdfs

Chairs: Dr. Chansay Ptthammavong (Deputy Director NIP, Lao PDR) & Dr. Cathy Ndiaye (PATH)

  • Country experiences on delivery strategies; Malaysia
    Dr. Saidatul Norbaya Binti Buang (Deputy EPI Director)
  • Country experiences on delivery strategies; Myanmar EPI
    Tin Thitsa Lwin (EPI)
  • Singapore’s experience on integrated HPV vaccine delivery
    Ms. Vasuki Utravathy (Health Promotion Board, MOH, Singapore)
  • Q&A
  • Panel Discussion on delivery Strategies, integration opportunities and targeting hard-to-reach population.
    • Moderator: Session 5c appointed chairpersons
      • Brunei – Dr. Norol-Ehsan Abd Hamid (School Health Services)
      • Indonesia – Ms. Anita Huroiyati (Ministry of Education, Directorate of Junior High School) – Online

Session 6: Scaling up from Sub-National to National Introduction

videos | pdfs

Chairs: Dr. Scott LaMontagne (JSI, US) & Dr. Tham Chi Dung (PATH, Vietnam)

  • Country presentation: challenges for scale-up to the National level – Philippines
    Dr. Carmina Paz Vera (DOH, Philippines)
  • Country presentation: challenges for scale-up to the National level – China
    Prof. Youlin Qiao (National Cancer Center, China)
  • Panel Discussion and Input from participants: Strategies and Lessons for Scaling Up to national HPV Vaccination.
    • Moderator: Session 6 appointed chairpersons
      • Philippines – Dr. Janis Asuncion Bunoan-Macazo (DOH, Philippines)
      • Vietnam – Dr. Thi Thanh Huyen Dang (EPI Manager)
      • Indonesia – Ms. Hashta Meyta (EPI representative)

Session 7: Monitoring and Evaluation

videos | pdfs

Chairs: Dr. Hiroki Akaba (WHO, Philippines) & Dr. Chris Morgan (Jhpiego, US)

  • Plenary session – Participating Countries
    • Lao PDR – Dr. Chansay Ptthammavong (Deputy Director NIP)
    • Malaysia – Dr. Fauziah Binti Abdullah (District Health Officer)
    • Myanmar – Dr. Kyan Kan Kaung Deputy EPI Office
    • Thailand – Dr. Suchada Jiamsiri Ministry of Health

Session 8: HPV Vaccine Procurement and Costs

videos | pdfs

Chairs: Dr. Sunate Chuenkitmongkol (National Vaccine Institute, Thailand) & Ms. Emily Kobayashi (Gavi)

  • Gavi transitioned and MICs countries pricing
    Mr. Jason Thompson (UNICEF)
  • HPV vaccine cost and procurement – transitioning out of Gavi support and self-procurement
    Dr. Didik Setiawan (ITAGI, Indonesia)
  • Accelerated Gavi transitioning experience and HPV vaccine procurement experience
    Dr. Kongxay Phounphenghack Xay (EPI Manager, Lao PDR)
  • Q&A

Session 9: Deep Dive into Scientific and Implementation Topics

Session 9a: Overview Presentation

videos | pdfs

Chairs: CHIC Secretariat – Prof. Alex Vorsters (University of Antwerp) & Nayab Waheed (University of Antwerp)

  • Overview presentations of breakout group topics
    Ms. Nayab Waheed (CHIC Secretariat, University of Antwerp)

Session 9b: Breakout Groups

videos | pdfs

Chairs: Each breakout group has assigned chairs

  • Breakout group 1: Funding opportunities and financial sustainability of HPV programs (including cost-effectiveness studies)
    • Moderators: Ms. Emily Kobayashi (Gavi) & regional stakeholder
  • Breakout group 2: Single-dose evidence, product choice and vaccine procurement process
    • Moderators: Dr. Cathy Ndiaye (PATH) & regional stakeholder
  • Breakout group 3: Implementation strategies (topics to be determined)
    • Moderators: Global (TBD) & regional stakeholder (Dr. Putri Herliana, CHAI)
  • Plenary Breakout

Session 10: Implementation Working Group

Facilitators: Dr. Chris Morgan (Jhpiego, US) & Dr. Ana Bolio (Vaccine Conidence Project, UK)

  • Introduction
  • Discussing and selecting top priority themes
  • Voting for priority themes

Day 3: 4 October 2024

Session 10: Implementation Working Group, con’t

videos | pdfs
  • Regional participant & CHIC secretariat

Part 1: Discussing best practices, barriers/challenges and actionable steps to address challenges

Facilitators: CHIC secretariat (Dr. Anissa Sidibe, Dr. Chris Morgan and Dr. Ana Bolio)& Regional facilitators TBC

  • Rotating thematic group discussion
    • Each group will spend 40 – 60 minutes at one theme – focused table, then rotate to the next table. During each 40-60 minutes session, they will focus on the assigned theme, sharing their experiences, discussing challenges, and identifying best practices.

Part 2: Participants to reconvene in their respective country groups to discuss action items for their countries

Facilitators: Dr. Chris Morgan, Ms. Elaine Charurat, Ms. Nayab Waheed) & Regional facilitators TBC

  • Discussion in country groups

Part 3: Plenary Discussion

videos | pdfs

Chairs: CHIC Secretariat (Dr. Anissa Sidibe & Dr.Chris Morgan (Jhpiego, US))

  • Plenary Feedback from countries on their action items
  • Plenary discussion and closing remarks

Poster Session

posters
  • HPV Vaccination Program in Indonesia: Effectiveness, Scale-Up Costs, Future Prospects, and Policy Recommendations
    • Didik Setiawan
  • Post-Introduction Evaluation of Human Papillomavirus Vaccination in Indonesia: a lesson learnt for future program
    • Dwi Endarti
  • Assessment Of Hpv Vaccination Strategies To Reach Out-Of-School Girls Across Indonesia
    • Lili Nur Indah Sari
  • Monitoring Temperature Excursions in HPV Vaccine Management in Indonesia: Insights from Internet of Things Digitalization
    • Septianita Hastuti
  • Integration To Improve Adolescent Health And HPV Vaccination In Laos
    • Thet Lynn
  • HPV ImmunizaTion CatcH-Up Program (HITCH-UP) in Malaysia: Policy, implementation strategy and status
    • Radziah Mohamad
  • Overview of Human Papillomavirus (HPV) Vaccine Introduction in Myanmar.
    • Soe Lwin Nyein
  • Leaving No One Behind: HPV Vaccination Programme – Malaysia
    • Vignesvari Subramaniam
  • Adverse Event Following HPV Vaccination in Thailand 2017 – 2024.
    • Jirapa Chimmanee
  • HPV Vaccination and Cervical Cancer Prevention Efforts in Thailand: From Initiative to Sustainability
    • Manatsanan Khansai
  • The effectiveness of the HPV vaccine as part of the National Immunization Program for preventing HPV infection in Thai schoolgirls after seven years following immunization.
    • Pornjarim Nilyanimit
  • Decision-Making Drivers of Adoption or Switch to a Single-Dose HPV Vaccination Schedule: Insights from 19 Countries
    • Erica N. Rosser
  • Accelerate of Human Papillomavirus Vaccine Introduction in Indonesia: A Policy Analysis
    • Hashta Meyta
  • Attitudes of parents and health workers toward HPV vaccine in Mongolia: A Nationwide Cross-Sectional Survey
    • Nansalmaa Khaidav
  • School-Based HPV Immunization: Findings From A Qualitative Study In Mongolia.
    • Dashpagam Otganbayar
  • Summary Report Of Experiences Of Human Papilloma Virus (Hpv) Introduction Focuses On The Introduction And Advocacy Preparatory
    • Manuel Mausiry
  • Evaluation Of The Vaccine Effectiveness Eleven Years After 4vhpv Vaccination Among Young Women In Mongolia
    • Tsetsegsaikhan Batmunkh